乌干达恶性疟原虫分离株对二氢叶酸还原酶抑制剂的敏感性下降与基因多态性相关
该研究对2016至2020年乌干达Tororo和Busia地区的559株恶性疟原虫分离株进行体外药敏测试,并对383株测序。结果显示PfDHFR耐药突变常见,突变数目与对乙胺嘧啶、环氯胍和P218的敏感性下降相关,但P218对突变株仍保持优异活性。
要点
- 乌干达分离株中PfDHFR突变51I、59R、108N普遍存在,164L占12.8%。
- 突变数目增加与乙胺嘧啶、环氯胍和P218的敏感性下降相关,但与氯胍无关。
- P218对四重突变株的中位IC50为5.7 nM,仍保持优异活性。
核心结论
- 耐药相关PfDHFR突变在乌干达分离株中常见,但P218对突变寄生虫仍保持优异活性。
研究设计与样本
- 研究对2016至2020年乌干达Tororo和Busia地区的559株分离株进行体外药敏测试,并对383株测序。
主要发现
- 测序分离株中51I占100%、59R占93.7%、108N占100%、164L占12.8%。
- 突变数目增加与对乙胺嘧啶、环氯胍和P218的敏感性下降相关,但与氯胍无关。
- P218对164位点混合基因型寄生虫中位IC50为1.4 nM,对纯四重突变株为5.7 nM。
临床怎么用
- P218对携带常见PfDHFR耐药突变的乌干达恶性疟原虫分离株仍保持优异体外活性,支持其作为候选抗疟药物继续开发。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Plasmodium falciparum dihydrofolate reductase (PfDHFR) inhibitors pyrimethamine and cycloguanil (the active metabolite of proguanil) have important roles in malaria chemoprevention, but drug resistance challenges their efficacies. A new compound, P218, was designed to overcome resistance, but drug-susceptibility data for P falciparum field isolates are limited. METHODS: We studied ex vivo PfDHFR inhibitor susceptibilities of 559 isolates from Tororo and Busia districts, Uganda, from 2016 to 2020, sequenced 383 isolates, and assessed associations between genotypes and drug-susceptibility phenotypes. RESULTS: Median half-maximal inhibitory concentrations (IC50s) were 42 100 nM for pyrimethamine, 1200 nM for cycloguanil, 13000 nM for proguanil, and 0.6 nM for P218. Among sequenced isolates, 3 PfDHFR mutations, 51I (100%), 59R (93.7%), and 108N (100%), were very common, as previously seen in Uganda, and another mutation, 164L (12.8%), had moderate prevalence. Increasing numbers of mutations were associated with decreasing susceptibility to pyrimethamine, cycloguanil, and P218, but not proguanil, which does not act directly against PfDHFR. Differences in P218 susceptibilities were modest, with median IC50s of 1.4 nM for parasites with mixed genotype at position 164 and 5.7 nM for pure quadruple mutant (51I/59R/108N/164L) parasites. CONCLUSIONS: Resistance-mediating PfDHFR mutations were common in Ugandan isolates, but P218 retained excellent activity against mutant parasites.
引用
- Kreutzfeld O, Tumwebaze PK, Byaruhanga O, et al. Decreased Susceptibility to Dihydrofolate Reductase Inhibitors Associated With Genetic Polymorphisms in Ugandan Plasmodium falciparum Isolates. J Infect Dis. 2022. PMID: 34460932. doi:10.1093/infdis/jiab435
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。